Bloomage Biotechnology Corp Ltd (688363) - Total Liabilities

Latest as of September 2025: CN¥1.38 Billion CNY ≈ $201.83 Million USD

Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) has total liabilities worth CN¥1.38 Billion CNY (≈ $201.83 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Bloomage Biotechnology Corp Ltd to assess how effectively this company generates cash.

Bloomage Biotechnology Corp Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how Bloomage Biotechnology Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Bloomage Biotechnology Corp Ltd's assets to evaluate the company's liquid asset resilience ratio.

Bloomage Biotechnology Corp Ltd Competitors by Total Liabilities

The table below lists competitors of Bloomage Biotechnology Corp Ltd ranked by their total liabilities.

Company Country Total Liabilities
NMI Holdings Inc
NASDAQ:NMIH
USA $1.25 Trillion
Apple Hospitality REIT Inc
NYSE:APLE
USA $1.72 Billion
Nuode Investment Co Ltd
SHG:600110
China CN¥10.02 Billion
Sportradar Group AG
NASDAQ:SRAD
USA $1.43 Billion
Kyndryl Holdings Inc
NYSE:KD
USA $9.97 Billion
Bank of Chongqing Co Ltd
SHG:601963
China CN¥956.75 Billion
Acadia Realty Trust
NYSE:AKR
USA $2.21 Billion
FB Financial Corp
NYSE:FBK
USA $14.26 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Bloomage Biotechnology Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Bloomage Biotechnology Corp Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.50 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.16 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bloomage Biotechnology Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bloomage Biotechnology Corp Ltd (2012–2024)

The table below shows the annual total liabilities of Bloomage Biotechnology Corp Ltd from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥1.82 Billion
≈ $265.87 Million
+22.22%
2023-12-31 CN¥1.49 Billion
≈ $217.53 Million
-25.63%
2022-12-31 CN¥2.00 Billion
≈ $292.48 Million
+10.96%
2021-12-31 CN¥1.80 Billion
≈ $263.58 Million
+189.28%
2020-12-31 CN¥622.68 Million
≈ $91.12 Million
+47.52%
2019-12-31 CN¥422.11 Million
≈ $61.77 Million
+19.39%
2018-12-31 CN¥353.56 Million
≈ $51.74 Million
+44.10%
2017-12-31 CN¥245.35 Million
≈ $35.90 Million
-42.07%
2016-12-31 CN¥423.53 Million
≈ $61.98 Million
-57.95%
2015-12-31 CN¥1.01 Billion
≈ $147.39 Million
+373.01%
2014-12-31 CN¥212.94 Million
≈ $31.16 Million
+4.40%
2013-12-31 CN¥203.96 Million
≈ $29.85 Million
+109.65%
2012-12-31 CN¥97.29 Million
≈ $14.24 Million
--

About Bloomage Biotechnology Corp Ltd

SHG:688363 China Specialty Chemicals
Market Cap
$2.91 Billion
CN¥19.86 Billion CNY
Market Cap Rank
#5074 Global
#990 in China
Share Price
CN¥41.24
Change (1 day)
-0.27%
52-Week Range
CN¥40.50 - CN¥60.00
All Time High
CN¥303.37
About

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature nam… Read more